LocoMMotion: a study of real-life current standards of care in triple-class exposed patients with relapsed/refractory multiple myeloma : 2-year follow-up (final analysis)

Treatment of relapsed/refractory multiple myeloma (RRMM) is challenging as patients exhaust all available therapies and the disease becomes refractory to standard drug classes. Here we report the final results of LocoMMotion, the first prospective study of real-world clinical practice (RWCP) in trip...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Mateos, Maria-Victoria (VerfasserIn) , Weisel, Katja (VerfasserIn) , De Stefano, Valerio (VerfasserIn) , Goldschmidt, Hartmut (VerfasserIn) , Delforge, Michel (VerfasserIn) , Mohty, Mohamad (VerfasserIn) , Dytfeld, Dominik (VerfasserIn) , Angelucci, Emanuele (VerfasserIn) , Vincent, Laure (VerfasserIn) , Perrot, Aurore (VerfasserIn) , Benjamin, Reuben (VerfasserIn) , van de Donk, Niels W. C. J. (VerfasserIn) , Ocio, Enrique M. (VerfasserIn) , Roccia, Tito (VerfasserIn) , Schecter, Jordan M. (VerfasserIn) , Koskinen, Silva (VerfasserIn) , Haddad, Imène (VerfasserIn) , Strulev, Vadim (VerfasserIn) , Mitchell, Lada (VerfasserIn) , Buyze, Jozefien (VerfasserIn) , Filho, Octavio Costa (VerfasserIn) , Einsele, Hermann (VerfasserIn) , Moreau, Philippe (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 25 September 2024
In: World psychiatry
Year: 2024, Jahrgang: 38, Heft: 12, Pages: 2554-2560
ISSN:2051-5545
DOI:10.1038/s41375-024-02404-6
Online-Zugang:Verlag, kostenfrei, Volltext: https://doi.org/10.1038/s41375-024-02404-6
Verlag, kostenfrei, Volltext: https://www.nature.com/articles/s41375-024-02404-6
Volltext
Verfasserangaben:María-Victoria Mateos, Katja Weisel, Valerio De Stefano, Hartmut Goldschmidt, Michel Delforge, Mohamad Mohty, Dominik Dytfeld, Emanuele Angelucci, Laure Vincent, Aurore Perrot, Reuben Benjamin, Niels W. C. J. van de Donk, Enrique M. Ocio, Tito Roccia, Jordan M. Schecter, Silva Koskinen, Imène Haddad, Vadim Strulev, Lada Mitchell, Jozefien Buyze, Octavio Costa Filho, Hermann Einsele, and Philippe Moreau

MARC

LEADER 00000caa a2200000 c 4500
001 1926540557
003 DE-627
005 20250717015129.0
007 cr uuu---uuuuu
008 250523s2024 xx |||||o 00| ||eng c
024 7 |a 10.1038/s41375-024-02404-6  |2 doi 
035 |a (DE-627)1926540557 
035 |a (DE-599)KXP1926540557 
035 |a (OCoLC)1528045595 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Mateos, Maria-Victoria  |e VerfasserIn  |0 (DE-588)1197091629  |0 (DE-627)1678922323  |4 aut 
245 1 0 |a LocoMMotion  |b a study of real-life current standards of care in triple-class exposed patients with relapsed/refractory multiple myeloma : 2-year follow-up (final analysis)  |c María-Victoria Mateos, Katja Weisel, Valerio De Stefano, Hartmut Goldschmidt, Michel Delforge, Mohamad Mohty, Dominik Dytfeld, Emanuele Angelucci, Laure Vincent, Aurore Perrot, Reuben Benjamin, Niels W. C. J. van de Donk, Enrique M. Ocio, Tito Roccia, Jordan M. Schecter, Silva Koskinen, Imène Haddad, Vadim Strulev, Lada Mitchell, Jozefien Buyze, Octavio Costa Filho, Hermann Einsele, and Philippe Moreau 
264 1 |c 25 September 2024 
300 |b Illustrationen 
300 |a 7 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 23.05.2025 
520 |a Treatment of relapsed/refractory multiple myeloma (RRMM) is challenging as patients exhaust all available therapies and the disease becomes refractory to standard drug classes. Here we report the final results of LocoMMotion, the first prospective study of real-world clinical practice (RWCP) in triple-class exposed (TCE) patients with RRMM, with a median follow-up of 26.4 months (range, 0.1-35.0). Patients (N  =  248) had received median 4 prior LOT (range, 2-13) at enrollment. 91 unique regimens were used in index LOT. Overall response rate was 31.9% (95% CI, 26.1-38.0), median progression-free survival (PFS) was 4.6 months (95% CI, 3.9-5.6) and median overall survival was 13.8 months (95% CI, 10.8-17.0). 152 patients (61.3%) had subsequent LOTs with 134 unique regimens, of which 78 were used in first subsequent LOT. Median PFS2 (from start of study through first subsequent LOT) was 10.8 months (95% CI, 8.4-13.0). 158 patients died on study, 67.7% due to progressive disease. Additional subgroup analyses and long-term safety summaries are reported. The high number of RWCP treatment regimens utilized and poor clinical outcomes confirm a lack of standardized treatment for TCE patients with RRMM, highlighting the need for new treatments with novel mechanisms. 
650 4 |a Cancer therapy 
650 4 |a Clinical trials 
700 1 |8 1\p  |a Weisel, Katja  |d 1971-  |e VerfasserIn  |0 (DE-588)118014935  |0 (DE-627)079191975  |0 (DE-576)291668887  |4 aut 
700 1 |a De Stefano, Valerio  |e VerfasserIn  |4 aut 
700 1 |a Goldschmidt, Hartmut  |d 1956-  |e VerfasserIn  |0 (DE-588)102258023X  |0 (DE-627)717003809  |0 (DE-576)365637386  |4 aut 
700 1 |a Delforge, Michel  |e VerfasserIn  |4 aut 
700 1 |a Mohty, Mohamad  |e VerfasserIn  |4 aut 
700 1 |a Dytfeld, Dominik  |e VerfasserIn  |4 aut 
700 1 |a Angelucci, Emanuele  |e VerfasserIn  |4 aut 
700 1 |a Vincent, Laure  |e VerfasserIn  |4 aut 
700 1 |a Perrot, Aurore  |e VerfasserIn  |4 aut 
700 1 |a Benjamin, Reuben  |e VerfasserIn  |4 aut 
700 1 |a van de Donk, Niels W. C. J.  |e VerfasserIn  |4 aut 
700 1 |a Ocio, Enrique M.  |e VerfasserIn  |4 aut 
700 1 |a Roccia, Tito  |e VerfasserIn  |4 aut 
700 1 |a Schecter, Jordan M.  |e VerfasserIn  |4 aut 
700 1 |a Koskinen, Silva  |e VerfasserIn  |4 aut 
700 1 |a Haddad, Imène  |e VerfasserIn  |4 aut 
700 1 |a Strulev, Vadim  |e VerfasserIn  |4 aut 
700 1 |a Mitchell, Lada  |e VerfasserIn  |4 aut 
700 1 |a Buyze, Jozefien  |e VerfasserIn  |4 aut 
700 1 |a Filho, Octavio Costa  |e VerfasserIn  |4 aut 
700 1 |8 2\p  |a Einsele, Hermann  |d 1958-  |e VerfasserIn  |0 (DE-588)130333840  |0 (DE-627)499570715  |0 (DE-576)217096875  |4 aut 
700 1 |a Moreau, Philippe  |e VerfasserIn  |0 (DE-588)1095523767  |0 (DE-627)856146544  |0 (DE-576)463046390  |4 aut 
773 0 8 |i Enthalten in  |t World psychiatry  |d Hoboken, NJ [u.a.] : Wiley-Blackwell, 2002  |g 38(2024), 12, Seite 2554-2560  |h Online-Ressource  |w (DE-627)512300828  |w (DE-600)2236130-3  |w (DE-576)281309663  |x 2051-5545  |7 nnas  |a LocoMMotion a study of real-life current standards of care in triple-class exposed patients with relapsed/refractory multiple myeloma : 2-year follow-up (final analysis) 
773 1 8 |g volume:38  |g year:2024  |g number:12  |g pages:2554-2560  |g extent:7  |a LocoMMotion a study of real-life current standards of care in triple-class exposed patients with relapsed/refractory multiple myeloma : 2-year follow-up (final analysis) 
856 4 0 |u https://doi.org/10.1038/s41375-024-02404-6  |x Verlag  |x Resolving-System  |z kostenfrei  |3 Volltext 
856 4 0 |u https://www.nature.com/articles/s41375-024-02404-6  |x Verlag  |z kostenfrei  |3 Volltext 
883 |8 1\p  |a cgwrk  |d 20250604  |q DE-101  |u https://d-nb.info/provenance/plan#cgwrk 
883 |8 2\p  |a cgwrk  |d 20250604  |q DE-101  |u https://d-nb.info/provenance/plan#cgwrk 
951 |a AR 
992 |a 20250523 
993 |a Article 
994 |a 2024 
998 |g 102258023X  |a Goldschmidt, Hartmut  |m 102258023X:Goldschmidt, Hartmut  |d 910000  |d 910100  |e 910000PG102258023X  |e 910100PG102258023X  |k 0/910000/  |k 1/910000/910100/  |p 4 
999 |a KXP-PPN1926540557  |e 4727278464 
BIB |a Y 
SER |a journal 
JSO |a {"language":["eng"],"person":[{"given":"Maria-Victoria","role":"aut","display":"Mateos, Maria-Victoria","family":"Mateos"},{"family":"Weisel","display":"Weisel, Katja","role":"aut","given":"Katja"},{"family":"De Stefano","display":"De Stefano, Valerio","role":"aut","given":"Valerio"},{"display":"Goldschmidt, Hartmut","family":"Goldschmidt","given":"Hartmut","role":"aut"},{"display":"Delforge, Michel","family":"Delforge","given":"Michel","role":"aut"},{"family":"Mohty","display":"Mohty, Mohamad","given":"Mohamad","role":"aut"},{"role":"aut","given":"Dominik","display":"Dytfeld, Dominik","family":"Dytfeld"},{"family":"Angelucci","display":"Angelucci, Emanuele","role":"aut","given":"Emanuele"},{"family":"Vincent","display":"Vincent, Laure","role":"aut","given":"Laure"},{"family":"Perrot","display":"Perrot, Aurore","given":"Aurore","role":"aut"},{"role":"aut","given":"Reuben","family":"Benjamin","display":"Benjamin, Reuben"},{"family":"van de Donk","display":"van de Donk, Niels W. C. J.","role":"aut","given":"Niels W. C. J."},{"display":"Ocio, Enrique M.","family":"Ocio","given":"Enrique M.","role":"aut"},{"family":"Roccia","display":"Roccia, Tito","role":"aut","given":"Tito"},{"given":"Jordan M.","role":"aut","family":"Schecter","display":"Schecter, Jordan M."},{"given":"Silva","role":"aut","display":"Koskinen, Silva","family":"Koskinen"},{"display":"Haddad, Imène","family":"Haddad","role":"aut","given":"Imène"},{"display":"Strulev, Vadim","family":"Strulev","role":"aut","given":"Vadim"},{"display":"Mitchell, Lada","family":"Mitchell","given":"Lada","role":"aut"},{"display":"Buyze, Jozefien","family":"Buyze","role":"aut","given":"Jozefien"},{"role":"aut","given":"Octavio Costa","family":"Filho","display":"Filho, Octavio Costa"},{"display":"Einsele, Hermann","family":"Einsele","given":"Hermann","role":"aut"},{"display":"Moreau, Philippe","family":"Moreau","role":"aut","given":"Philippe"}],"id":{"eki":["1926540557"],"doi":["10.1038/s41375-024-02404-6"]},"physDesc":[{"extent":"7 S.","noteIll":"Illustrationen"}],"name":{"displayForm":["María-Victoria Mateos, Katja Weisel, Valerio De Stefano, Hartmut Goldschmidt, Michel Delforge, Mohamad Mohty, Dominik Dytfeld, Emanuele Angelucci, Laure Vincent, Aurore Perrot, Reuben Benjamin, Niels W. C. J. van de Donk, Enrique M. Ocio, Tito Roccia, Jordan M. Schecter, Silva Koskinen, Imène Haddad, Vadim Strulev, Lada Mitchell, Jozefien Buyze, Octavio Costa Filho, Hermann Einsele, and Philippe Moreau"]},"recId":"1926540557","relHost":[{"part":{"volume":"38","extent":"7","text":"38(2024), 12, Seite 2554-2560","issue":"12","pages":"2554-2560","year":"2024"},"language":["eng"],"type":{"bibl":"periodical","media":"Online-Ressource"},"disp":"LocoMMotion a study of real-life current standards of care in triple-class exposed patients with relapsed/refractory multiple myeloma : 2-year follow-up (final analysis)World psychiatry","title":[{"subtitle":"official journal of the World Psychiatric Association","title_sort":"World psychiatry","title":"World psychiatry"}],"pubHistory":["1.2002 -"],"note":["Gesehen am 10.09.19"],"origin":[{"publisherPlace":"Hoboken, NJ [u.a.]","dateIssuedDisp":"2002-","publisher":"Wiley-Blackwell","dateIssuedKey":"2002"}],"id":{"issn":["2051-5545"],"zdb":["2236130-3"],"eki":["512300828"]},"physDesc":[{"extent":"Online-Ressource"}],"recId":"512300828"}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"title":[{"title_sort":"LocoMMotion","subtitle":"a study of real-life current standards of care in triple-class exposed patients with relapsed/refractory multiple myeloma : 2-year follow-up (final analysis)","title":"LocoMMotion"}],"note":["Gesehen am 23.05.2025"],"origin":[{"dateIssuedDisp":"25 September 2024","dateIssuedKey":"2024"}]} 
SRT |a MATEOSMARILOCOMMOTIO2520